Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

The Imaging Compass: Navigating Reperfusion in Acute Ischemic Stroke.

Created on 26 Aug 2026

Authors

Kai Xu, Jinhao Lyu, Xin Lou

Published in

Journal of magnetic resonance imaging : JMRI. Aug 25, 2026. Epub Aug 25, 2026.

Abstract

The management of acute ischemic stroke has shifted from rigid time-based protocols to imaging-driven, tissue-based reperfusion strategies. Non-contrast CT and CT angiography remain the indispensable frontline for rapid triage, particularly in community and low-resource settings. However, magnetic resonance imaging (MRI) provides unique biological information that complements CT-based assessment: Diffusion-weighted imaging (DWI) detects cellular ischemia within minutes without contrast; DWI-fluid-attenuated inversion recovery (FLAIR) mismatch serves as a tissue clock for unknown-onset stroke; susceptibility-weighted imaging (SWI) aids thrombus characterization; and MRI resolves the posterior fossa without beam-hardening artifact. Low-field portable MRI further extends these capabilities to the bedside where conventional scanners are unavailable. This review examines four convergent trends within this transition: expanding thrombectomy to large-core infarction, extending thrombolysis through tissue-based selection, advancing recanalization in posterior-circulation stroke while defining boundaries for medium- and distal-vessel occlusions, and simplifying imaging workflows through fast MRI protocols, quantitative CT biomarkers, and artificial intelligence (AI). Landmark trials have established that treatment benefit is determined by tissue viability rather than clock time, while recent negative trials define critical boundaries beyond which intervention may cause harm. We critically appraise how CT and MRI are integrated hierarchically across these scenarios, and how emerging fast MRI and quantitative biomarkers may reshape future selection paradigms. EVIDENCE LEVEL: 3-4. TECHNICAL EFFICACY: 3.

PMID:
42642837
Bibliographic data and abstract were imported from PubMed on 26 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement